Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: No difference in related compared with unrelated transplant in first complete remission

Journal of Clinical Oncology

Volumn 22, Issue 14, 2004, Pages 2816-2825

  Kiehl, Michael G ^a   Kraut, Ludwig ^a   Schwerdtfeger, Rainer ^a   Hertenstein, Bernd ^a   Remberger, Mats ^a   Kroeger, Nicolaus ^a   Stelljes, Mathias ^a   Bornhaeuser, Martin ^a   Martin, Hans ^a   Scheid, Christoph ^a   Ganser, Arnold ^a   Zander, Axel R ^a   Kienast, Joachim ^a   Ehninger, Gerhard ^a   Hoelzer, Dieter ^a   Diehl, Volker ^a   Fauser, Axel A ^a   Ringden, Olle ^a  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ALLOTRANSPLANTATION; CLINICAL TRIAL; DONOR; FAMILY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; REMISSION; SURVIVAL;

ADOLESCENT; ADULT; FAMILY; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; REMISSION INDUCTION; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 4344682975     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.07.130     Document Type: Article

References (33)

1. Xie Y, Davies SM, Xiang Y, et al: Trends in leukemia incidence and survival in the United States (1973-1998). Cancer 97:2229-2235, 2003
2. Durrent JJ, Prentice HG, Richards SM: Intensification of treatment for adults with acute lymphoblastic leukaemia: Results of U.K. Medical Research Council randomized trial UKALL XA-Medical Research Council Working Party on Leukaemia in Adults. Br J Haematol 99:84-92, 1997
3. Ribera JM, Ortega JJ, Oriol A, et al: Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia: Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Soc Hematol 83:222-230, 1998
4. Finiewicz KJ, Larson RA: Dose-intensive therapy for adult acute lymphoblastic leukemia. Semin Oncol 26:6-20, 1999
5. Larson RA, Dodge RK, Linker CA, et al: A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 92:1556-1564, 1998
6. Kantarjian HM, Brien S, Smith TL, et al: Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 18:547-561, 2000
7. Hoelzer D, Gokbuget N: Recent approaches in acute lymphoblastic leukemia in adults. Crit Rev Oncol Hematol 36:49-58, 2000
8. Rowe JM, Richards SM, Burnett AK, et al: Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-Chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 98, 2001 (abstr 2009)
9. Thiebaut A, Vernant JP, Degos L: Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation: A follow-up report of the French protocol LALA 87. Hematol Oncol Clin North Am 14:1353-1366, 2000
10. International Bone Marrow Transplant Registry. 2002. Internet Communication
11. National Marrow Donor Program. 2002. Internet Communication
12. Thiede C, Bornhauser M, Oelschlagel U, et al: Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia 15:293-302, 2001
13. Mattsson J, Uzunel M, Remberger M, et al: T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Transplantation 71:433-439, 2001
14. Zetterquist H, Mattsson J, Uzunel M, et al: Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia. Bone Marrow Transplant 25:843-851, 2000
15. Diez M, Llamas P, Gosalvez J, et al: Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI). Haematologica 83:408-415, 1998
16. Joékowska J, Wachowiak J, Lange A, et al: Molecular assessment of post-BMT chimerism using various biologic specimens and automated DNA sizing technology. J Hematother Stem Cell Res 9:263-268, 2000
17. Przepiorka D, Weisdorf D, Martin P, et al: 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15:825-828, 1995
18. Vogelsang GB: How I treat chronic graft-versus-host disease. Blood 97:1196-1201, 2001
19. Hoelzer D. Acute lymphocytic leukemia in adults, in Hoffmann R, Benz JS, Shattil SJ, et al (eds): Hematology. New York, NY. Churchill Livingston, 2003, pp1089-1105
20. Pero R, Peto J: Asymptotically efficient rank invariation test procedures. J R Stat Soc A 135:185-207, 1972
21. Cox DR: Regression models and life tables. J R Stat Soc 34:187-202, 1972
22. Annino L, Vegna ML, Camera A, et al: Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood 99:863-871, 2002
23. Bunin N, Carston M, Wall D, et al: Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 99:3151-3157, 2002
24. Cornelissen JJ, Carston M, Kollman C, et al: Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: Strong graft-versus-leukemia effect and risk factors determining outcome. Blood 97:1572-1577, 2001
25. Ringden O, Hermans J, Labopin M, et al: The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease: Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT). Leukemia Lymphoma 24:71-79, 1996
26. Horowitz MM, Gale RP, Sondel PM, et al: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555-562, 1990
27. Yazaki M. Andoh M, Ito T, et al: Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion. Bone Marrow Transplant 19:393-394, 1997
28. Keil F, Kalhs P, Haas OA, et al: Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: Sustained molecular remission after early and dose-escalating infusion of donor leucocytes. Br J Haematol 97:161-164, 1997
29. Storb RF, Champlin R, Riddell SR, et al: Non-myeloablative transplants for malignant disease. Hematology 1:375-391, 2001
30. Esperou H, Boiron JM, Cayuela JM, et al: A potential graft-versus- leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from the French Bone Marrow Transplantation Society. Bone Marrow Transplant 31:909-918, 2003
31. Socie G, Clift RA, Blaise D, et al: Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: Long-term follow-up of 4 randomized studies. Blood 98:3569-3574, 2001
32. Ringden O, Remberger M, Ruutu T, et al: Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: Long-term results of a randomized trial in allogeneic marrow recipients with leukemia-Nordic Bone Marrow Transplantation Group. Blood 93:2196-2201, 1999
33. Ringden O, Labopin M, Tura S, et al: A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia: Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 93:637-645, 1996